Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
SONN similar filings
- 30 Sep 24 Material Modifications to Rights of Security Holders
- 18 Sep 24 Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors
- 12 Sep 24 Submission of Matters to a Vote of Security Holders
- 9 Sep 24 Regulation FD Disclosure
- 30 Aug 24 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- 19 Aug 24 Regulation FD Disclosure
- 14 Aug 24 Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
Filing view
External links